Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Rb1/Rbl1/Vhl loss induces mouse subretinal angiomatous proliferation and hemangioblastoma
Ran Wei, Xiang Ren, Hongyu Kong, Zhongping Lv, Yongjiang Chen, Yunjing Tang, Yujiao Wang, Lirong Xiao, Tao Yu, Sabiha Hacibekiroglu, Chen Liang, Andras Nagy, Rod Bremner, Danian Chen
Ran Wei, Xiang Ren, Hongyu Kong, Zhongping Lv, Yongjiang Chen, Yunjing Tang, Yujiao Wang, Lirong Xiao, Tao Yu, Sabiha Hacibekiroglu, Chen Liang, Andras Nagy, Rod Bremner, Danian Chen
View: Text | PDF
Research Article Angiogenesis Ophthalmology

Rb1/Rbl1/Vhl loss induces mouse subretinal angiomatous proliferation and hemangioblastoma

  • Text
  • PDF
Abstract

Von Hippel–Lindau (Vhl) protein inhibits hypoxia-inducible factor (Hif), yet its deletion in murine retina does not cause the extensive angiogenesis expected with Hif induction. The mechanism is unclear. Here we show that retinoblastoma tumor suppressor (Rb1) constrains expression of Hif target genes in the Vhl–/– retina. Deleting Rb1 induced extensive retinal neovascularization and autophagic ablation of photoreceptors in the Vhl–/– retina. RNA-sequencing, ChIP, and reporter assays showed Rb1 recruitment to and repression of certain Hif target genes. Activating Rb1 by deleting cyclin D1 induced a partial defect in the retinal superficial vascular plexus. Unexpectedly, removing Vhl suppressed retinoblastoma formation in murine Rb1/Rbl1–deficient retina but generated subretinal vascular growths resembling retinal angiomatous proliferation (RAP) and retinal capillary hemangioblastoma (RCH). Most stromal cells in the RAP/RCH–like lesions were Sox9+, suggesting a Müller glia origin, and expressed Lgals3, a marker of human brain hemangioblastoma. Thus, the Rb family limit Hif target gene expression in the Vhl–/– retina, and removing this inhibitory signal generates new models for RAP and RCH.

Authors

Ran Wei, Xiang Ren, Hongyu Kong, Zhongping Lv, Yongjiang Chen, Yunjing Tang, Yujiao Wang, Lirong Xiao, Tao Yu, Sabiha Hacibekiroglu, Chen Liang, Andras Nagy, Rod Bremner, Danian Chen

×

Figure 3

Rb1 directly inhibits Vhl-null–induced angiogenesis and autophagy.

Options: View larger image (or click on image) Download as PowerPoint
Rb1 directly inhibits Vhl-null–induced angiogenesis and autophagy.
(A) R...
(A) Representative Western blots of indicated proteins in retinas of indicated genotypes. (B) The quantification of total protein level relative to β-actin in A. (C) Gene list enrichment analysis using Kyoto Encyclopedia of Genes (KEGG) 2016 data sets in Enrichr of Rb1+/– Vhl–/– and Rb1/Vhl–DKO regulated DEGs (−log10 P). Dotted line, P < 0.05. (D) Heatmap of top 7 pathways of Vhl-, Rb1-, and Rbl1-regulated DEGs by RNA-sequencing. (E) The relative mRNA levels of indicated genes and indicated genotypes were analyzed by real-time PCR (RT-PCR). (F) ChIP using Rb1 antibody at the promoter of indicated genes and treatments in WT retinal explant cultured from P8 to P11. The enrichment of Rb1 was quantified using quantitative PCR and normalized to input. (G) Luciferase reporter assay. HEK293T cells were transfected with indicated luciferase reporter plasmid, and pSG5L-HA-RB or pSG5L plasmid, by Lipofectamine. Renilla luciferase plasmid was included to normalize for transfection efficiency. Error bars represent SD (B and G) or SEM (in E and F) of measurements from 3 retinas (B, E, and F; n = 3) or 3 assays (G; n = 3), and asterisks indicate significant differences between WT and indicated genotypes in B and E; or between IgG no CoCl2 treatment and other indicated treatments in F, between pSG5L-HA-RB and pSG5L vector in G (*P < 0.05, **P < 0.01, 1-way ANOVA followed by Bonferroni’s correction).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts